Ajay Shah, PhD
Co-Founder and CEO
Ajay is an expert in cell-based diagnostic technologies, as well as an experienced entrepreneur, having previously co-founded two life science companies (one acquired in 2012). Ajay received his Ph.D. from the Harvard-MIT Division of Health Sciences and Technology, where he developed a novel platform for circulating tumor cell isolation under the supervision of Mehmet Toner and Daniel Haber at Mass. General Hospital.
Mara Macdonald, PhD
Co-Founder and COO
Mara currently serves as the co-founder and Chief Operations Officer at CytoVale and manages aspects of company building, strategic marketing, and regulatory and clinical operations. Prior to CytoVale, Mara worked with Third Rock Ventures, a venture capital firm focused on launching and building life science companies. Mara earned her PhD from the Harvard-MIT Division of Health Sciences & Technology.
Henry Tse, PhD
Co-Founder and VP Engineering
Henry is Co-Founder and Vice-President of Engineering for CytoVale, leading the research and development efforts to commercialize the microfluidic deformability cytometry technology. Henry's broad engineering and science background is rooted in his graduate work with Professor Dino Di Carlo. His science and engineering expertise spans microfluidics, cancer biology, image processing, and application proof-of-concept clinical studies. Henry is the co-inventor of the deformability cytometry platform, which has resulted in peer-reviewed publications of seminal papers of the technology, followed on by application specific papers, as well an accompanying suite of issued patents.